C2-O-sLeX Glycoproteins are E-Selectin ligands that regulate invasion of human colon and hepatic carcinoma cells

PLoS ONE

Volumn 6, Issue 1, 2011, Pages

  St Hill, Catherine A ^a   Baharo Hassan, Dahabo ^a   Farooqui, Mariya ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2,3 FUCOSYLTRANSFERASE; CORE 2 BETA 1,6 N ACETYLGLUCOSAMINYLTRANSFERASE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; EPITOPE; FUCOSYLTRANSFERASE; GLYCAN; L SELECTIN; MATRIGEL; MESSENGER RNA; N ACETYLGLUCOSAMINYLTRANSFERASE; PADGEM PROTEIN; SHORT HAIRPIN RNA; SIALYL LEWIS X MODIFIED CORE 2 O GLYCAN; UNCLASSIFIED DRUG; BETA 1,3 GALACTOSYL O GLYCOSYL GLYCOPROTEIN BETA 1,6 ACETYLGLUCOSAMINYL TRANSFERASE; BETA-1,3-GALACTOSYL-O-GLYCOSYL-GLYCOPROTEIN BETA-1,6-ACETYLGLUCOSAMINYL TRANSFERASE; CY 1503; GLYCOPROTEIN; LIGAND; OLIGOSACCHARIDE;

ARTICLE; BINDING AFFINITY; BINDING SITE; CANCER CELL CULTURE; CANCER INVASION; CARBOHYDRATE SYNTHESIS; CELL ADHESION; COLON CARCINOMA; CONTROLLED STUDY; DOWN REGULATION; ENZYME REGULATION; FLOW CYTOMETRY; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; LIVER CARCINOMA; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; CHEMISTRY; COLON TUMOR; GENETICS; LIVER CELL CARCINOMA; METABOLISM; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE;

CARCINOMA, HEPATOCELLULAR; CELL ADHESION; CELL LINE, TUMOR; COLONIC NEOPLASMS; E-SELECTIN; EPITOPES; GLYCOPROTEINS; HUMANS; LIGANDS; N-ACETYLGLUCOSAMINYLTRANSFERASES; NEOPLASM INVASIVENESS; OLIGOSACCHARIDES; RNA, MESSENGER;

EID: 79251605755     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0016281     Document Type: Article

References (65)

1. Berg EL, Magnani J, Warnock RA, Robinson MK, Butcher EC (1992) Comparison of L-selectin and E-selectin ligand specificities: the L-selectin can bind the E-selectin ligands sialyl Le(x) and sialyl Le(a). Biochem Biophys Res Commun 184: 1048-1055.
2. Lafrenie RM, Buchanan MR, Orr FW (1993) Adhesion molecules and their role in cancer metastasis. Cell Biophys 23: 3-89.
3. Mannori G, Crottet P, Cecconi O, Hanasaki K, Aruffo A, et al. (1995) Differential colon cancer cell adhesion to E-, P-, and L-selectin: role of mucintype glycoproteins. Cancer Res 55: 4425-4431.
4. Lewinsohn DM, Bargatze RF, Butcher EC (1987) Leukocyte-endothelial cell recognition: evidence of a common molecular mechanism shared by neutrophils, lymphocytes, and other leukocytes. J of Immunol 138: 4313-4321.
5. Larsen E, Palabrica T, Sajer S, Gilbert GE, Wagner DD, et al. (1990) PADGEM-dependent adhesion of platelets to monocytes and neutrophils is mediated by a lineage-specific carbohydrate, LNF III (CD15). Cell 63: 467-474.
6. Geng JG, Bevilacqua MP, Moore KL, McIntyre TM, Prescott SM, et al. (1990) Rapid neutrophil adhesion to activated endothelium mediated by GMP-140. Nature 343: 757-760.
7. Bevilacqua MP, Pober JS, Mendrick DL, Cotran RS, Gimbrone MAJ (1987) Identification of an inducible endothelial-leukocyte adhesion molecule. Proc Natl Acad Sci USA 84: 9238-9242.
8. Lowe JB (2002) Glycosylation in the control of selectin counter-receptor structure and function. Immunol Rev 186: 19-36.
9. Ellies LG, S. T, Petryniak B, Lowe JB, Fukada M, et al. (1998) Core 2 oligosaccharide biosynthesis distinguishes between selectin ligands essential for leukocyte homing and inflammation. Immunity 9: 881-890.
10. Sperandio M, Thatte A, Foy D, Ellies LG, Marth JD, et al. (2001) Severe impairment of leukocyte rolling in venules of core 2 glucosaminyltransferasedeficient mice. Blood 97: 3812-3819.
11. Leppänen A, Mehta P, Ouyang YB, Ju T, Helin J, et al. (1999) A novel glycosulfopeptide binds to P-selectin and inhibits leukocyte adhesion to Pselectin. J Biol Chem 274: 24838-24848.
12. Li F, Wilkins PP, Crawley S, Weinstein J, Cummings RD, et al. (1996) Posttranslational modifications of recombinant P-selectin glycoprotein ligand-1 required for binding to P- and E-selectin. J Biol Chem 271: 3255-3264.
13. Ramachandran V, Nollert MU, Qui H, Liu WJ, Cummings RD, et al. (1999) Tyrosine replacement in P-selectin glycoprotein ligand-1 affects distinct kinetic and mechanical properties of bonds with P- and L-selectin. Proc Natl Acad Sci USA 96: 13771-13776.
14. Epperson TK, Patel KD, McEver RP, Cummings RD (2000) Noncovalent association of P-selectin glycoprotein ligand-1 and minimal determinants for binding to P-selectin. J Biol Chem 275: 7839-7853.
15. Kannagi R, Izawa M, Koike T, Miyazaki K, Kimura N (2004) Carbohydratemediated cell adhesion in cancer metastasis and angiogenesis. Cancer Sci 95: 377-384.
16. Irimura T, Nakamori S, Matsushita Y, Taniuchi Y, Todoroki N, et al. (1993) Colorectal cancer metastasis determined by carbohydrate-mediated cell adhesion: role of sialyl-Lex antigens. Semin Cancer Biol 4: 319-324.
17. Nakamori S, Kameyama M, Imaoka S, Furukawa H, Ishikawa O, et al. (1993) Increased expression of sialyl Lewisx antigen correlates with poor survival in patients with colorectal carcinoma: clinicopathological and immunohistochemical study. Cancer Res 53: 3632-3637.
18. Renkonen J, Paavonen T, Renkonen R (1997) Endothelial and epithelial expression of sialyl Lewis(x) and sialyl Lewis(a) in lesions of breast carcinoma. Int J Cancer 74: 296-300.
19. Haier J, Nasralla M, Nicolson G (2000) Cell surface molecules and their prognostic values in assessing colorectal carcinomas. Ann Surg 231: 11-24.
20. Renkonen J, Heinävaara S, Sankila R, Paavonen T (2000) Endothelial and epithelial expression of sialyl Lewis x in squamous carcinoma of the tongue. APMIS 108: 705-712.
21. Pauli BU, Augustin-Voss HG, el-Sabban ME, Johnson RC, Hammer DA (1990) Organ-preference of metastasis. The role of endothelial cell adhesion molecules. Cancer Metastasis Rev 9: 175-189.
22. Ito K, Ye CL, Hibi K, Mitsuoka C, Kannagi R, et al. (2001) Paired tumor marker of soluble E-selectin and its ligand sialyl Lewis A in colorectal cancer. J Gastroenterol 36: 823-829.
23. Zhang BH, Chen H, Yao XP, Cong WM, Wu MC (2002) E-selectin and its ligand-sLeX in the metastasis of hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int 1: 80-82.
24. Hakomori S (1996) Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism. Cancer Res 56: 5309-5318.
25. St. Hill CA, Bullard KM, Walcheck B (2005) Expression of the high-affinity selectin glycan ligand C2-O-sLeX by colon carcinoma cells. Cancer Lett 217: 105-113.
26. St. Hill CA, Farooqui M, Mitcheltree G, Gulbahce HE, Jessurun J, et al. (2009) The high affinity selectin glycan ligand C2-O-sLex and mRNA transcripts of the core 2 beta-1,6-N-acetylglucosaminyltransferase (C2GnT1) gene are highly expressed in human colorectal adenocarcinomas. BMC Cancer 9: 79.
27. Mitsakos A, Hanisch FG, Uhlenbruck G (1988) Biosynthesis of the cancerassociated sialyl-Lex determinant in human amniotic fluid. Biol Chem Hoppe- Seyler 369: 661-665.
28. Walcheck B, Leppänen A, Cummings RD, Knibbs RN, Stoolman LM, et al. (2002) The monclonal antibody CHO-131 binds to a core 2 O-glycan terminated with sialyl-Lewis x, which is a functional glycan ligand for P-selectin. Blood 99: 4063-4069.
29. Yago T, Leppanen A, Carlyon JA, Akkoyunlu M, Karmakar S, et al. (2003) Structurally distinct requirements for binding of P-selectin glycoprotein ligand-1 and sialyl Lewis x to Anaplasma phagocytophilum and P-selectin. J Biol Chem 278: 37987-37997.
30. Smith MJ, Smith BR, Lawrence MB, Snapp KR (2004) Functional analysis of the combined role of the O-linked branching enzyme core 2 beta1-6-Nglucosaminyltransferase and dimerization of P-selectin glycoprotein ligand-1 in rolling on P-selectin. J Biol Chem 279: 21984-21991.
31. Shimodaira K, Nakayama J, Nakamura N, Hasebe O, Tsutomu K, et al. (1997) Carcinoma-associated expression of core 2 b-1,6-N-acetylglucosaminyltransferase gene in human colorectal cancer: role of O-glycans in tumor progression. Cancer Res 57: 5201-5206.
32. Machida E, Nakayama J, Amano J, Fukuda M (2001) Clinicopathological significance of core 2 b1,6-N-acetylglucosaminyltransferase messenger RNA expressed in the pulmonary adenocarcinoma determined by in situ hybridization. Cancer Res 61: 2226-2231.
33. Renkonen J, Räbinā J, Mattila P, Grenman R, Renkonen R (2001) Core 2 b1,6- N-acetylglucosaminyltransferases and a1,3-fucosyltransferases regulate the synthesis of O-glycans on selectin ligands on oral cavity carcinoma cells. APMIS 109: 500-506.
34. Weiss L, Orr FW, Honn KV (1989) Interactions between cancer cells and the microvasculature: a rate-regulator for metastasis. Clin Exp Metastasis 7: 127-167.
35. Brockhausen I, Kuhns W, Schachter H, Matta KL, Sutherland DR, et al. (1991) Biosynthesis of O-glycans in leukocytes from normal donors and from patients with leukemia: increase in O-glycan core 2 UDP-GlcNAc:Gal beta 3 GalNAc alpha-R (GlcNAc to GalNAc) beta(1-6)-N-acetylglucosaminyltransferase in leukemic cells. Cancer Res 51: 1257-1263.
36. Saitoh O, Piller F, Fox RI, Fukuda M (1991) T-lymphocytic leukemia expresses complex, branched O-linked oligosaccharides on a major sialoglycoprotein, leukosialin. Blood 77: 1491-1499.
37. Yousefi S, Higgins E, Daoling Z, Pollex-Krüger A, Hindsgaul O, et al. (1991) Increased UDP-GlcNAc:Gal beta 1-3GaLNAc-R (GlcNAc to GaLNAc) beta-1, 6-N-acetylglucosaminyltransferase activity in metastatic murine tumor cell lines. Control of polylactosamine synthesis. J Biol Chem 266: 1772-1782.
38. Hagisawa S, Ohyama C, Takahashi T, Endoh M, Moriya T, et al. (2005) Expression of core 2 b1,6-N-acetylglucosaminyltransferase facilitates prostate cancer progression. Glycobiology 15: 1016-1024.
39. Sawada R, Tsuboi S, Fukuda M (1994) Differential E-selectin-dependent adhesion efficiency in sublines of human colon cancer exhibiting distinct metastatic potentials. J Biol Chem 269: 1425-1431.
40. Beum PV, Singh J, Burdick M, Hollingsworth M, Cheng PW (1999) Expression of core 2 b-1,6-N-acetylglucosaminyltransferase in a human pancreatic cancer cell line results in altered expression of MUC1 tumor associated epitopes. J Biol Chem 274: 24641-24648.
41. Singh PK, Hollingsworth MA (2006) Cell surface-associated mucins in signal transduction. Trends Cell Biol 16: 467-476.
42. Nakamori S, Ota DM, Cleary KR, Shirotani K, Irimura T (1994) MUC1 mucin expression as a marker of progression and metastasis of human colorectal carcinoma. Gastroenterology 106: 353-361.
43. Hiraga Y, Tanaka S, Haruma K, Yoshihara M, Sumii K, et al. (1998) Immunoreactive MUC1 expression at the deepest invasive portion correlates with prognosis of colorectal cancer. Oncology 55: 307-319.
44. Lee MJ, Lee HS, Kim WH, Choi Y, Yang M (2003) Expression of mucins and cytokeratins in primary carcinomas of the digestive system. Mod Pathol 16: 403-410.
45. Zhang K, Baeckström D, Brevinge H, Hansson GC (1996) Secreted MUC1 mucins lacking their cytoplasmic part and carrying sialyl-Lewis a and x epitopes from a tumor cell line and sera of colon carcinoma patients can inhibit HL-60 leukocyte adhesion to E-selectin-expressing endothelial cells. J Cell Biochem 60: 538-549.
46. Leeman MF, Curran S, Murray GI (2003) New insights into the roles of matrix metalloproteinases in colorectal cancer development and progression. J Pathol 201: 528-534.
47. Harada T, Arii S, Mise M, Imamura T, Higashitsuji H, et al. (1998) Membranetype matrix metalloproteinase-1(MT1-MTP) gene is overexpressed in highly invasive hepatocellular carcinomas. J Hepatol 28: 231-239.
48. Thathiah A, Carson DD (2004) MT1-MMP mediates MUC1 shedding independent of TACE/ADAM17. Biochem J 382(Pt 1): 363-373.
49. Napier SL, Healy ZR, Schnaar RL, Konstantopoulos K (2007) Selectin ligand expression regulates the initial vascular interactions of colon carcinoma cells: the roles of CD44V and alternative sialofucosylated selectin ligands. J Biol Chem 282: 3433-3441.
50. Ratnikov BI, Rozanov DV, Postnova TI, Baciu PG, Zhang H, et al. (2002) An alternative processing of integrin alpha(v) subunit in tumor cells by membrane type-1 matrix metalloproteinase. J Biol Chem 277: 7377-7385.
51. Bates RC, Bellovin DI, Brown C, Maynard E, Wu B, et al. (2005) Transcriptional activation of integrin beta6 during the epithelial-mesenchymal transition defines a novel prognostic indicator of aggressive colon carcinoma. J Clin Invest. pp 339-347.
52. Dalziel M, Whitehouse C, McFarlane I, Brockhausen I, Gschmeissner S, et al. (2001) The relative activities of the C2GnT1 and ST3Gal-I glycosyltransferases determine O-glycan structure and expression of a tumor-associated epitope on MUC1. J Biol Chem 276: 11007-11015.
53. De Graaf TW, Van der Stelt ME, Anbergen MG, van Dijk W (1993) Inflammation-induced expression of sialyl Lewis X-containing glycan structures on alpha 1-acid glycoprotein (orosomucoid) in human sera. J Exp Med 177: 657-666.
54. Katnik I, Goodarzi MT, Turner GA (1996) An improved ELISA for the determination of sialyl Lewis(x) structures on purified glycoconjugates. Glycoconj J 13: 1043-1047.
55. Brinkman-van der Linden EC, de Haan PF, Havenaar EC, van Dijk W (1998) Inflammation-induced expression of sialyl LewisX is not restricted to alpha1- acid glycoprotein but also occurs to a lesser extent on alpha1-antichymotrypsin and haptoglobin. Glycoconj J 15: 177-182.
56. Kannagi R, Izawa M, Koike T, Miyazaki K, Kimura N (2004) Carbohydratemediated cell adhesion in cancer metastasis and angiogenesis. Cancer Sci 95: 377-384.
57. Williams D, Schachter H (1980) Mucin synthesis. I. Detection in canine submaxillary glands of an N-acetylglucosaminyltransferase which acts on mucin substrates. J Biol Chem 255: 11247-11252.
58. Bierhuizen MF, Fukuda M (1992) Expression cloning of a cDNA encoding UDP-GlcNAc:Gal beta 1-3-GalNAc-R (GlcNAc to GalNAc) beta 1-6GlcNAc transferase by gene transfer into CHO cells expressing polyoma large tumor antigen. Proc Natl Acad Sci USA 89: 9326-9330.
59. Huang M-C, Chen H-Y, Huang H-C, Huang J, Liang J-T, et al. (2006) C2GnTM is downregulated in colorectal cancer and its re-expression causes growth inhibition of colon cancer cells. Oncogene 25: 3267-3276.
60. Descheny L, Gainers ME, Walcheck B, Dimitroff CJ (2006) Ameliorating skinhoming receptors on malignant T cells with a fluorosugar analog of Nacetylglucosamine: P-selectin ligand is a more sensitive target than E-selectin ligand. J Invest Dermatol 126: 2065-2073.
61. Ni Z, Campbell JJ, Niehans G, Walcheck B (2006) The monoclonal antibody CHO-131 identifies a subset of cutaneous lymphocyte-associated antigen T cells enriched in P-selectin-binding cells. J Immunol 177: 4742-4748.
62. Urdal DL, Brentrall TA, Bernstein ID, Hakomori S-l (1983) A granulocyte reactive monoclonal antibody, 1G10, identifies the Gal/3-4 (Fuc a 1-3) GlcNAc (X determinant) expressed in HL-60 cells on both glycolipid and glycoprotein molecules. Blood 62 1022-1026.
63. St. Hill CA, Alexander SR, Walcheck B (2003) Indirect capture augments leukocyte accumulation on P-selectin in flowing whole blood. J Leukoc Biol 73: 464-471.
64. Lawrence MB, Springer TA (1991) Leukocytes roll on a selectin at physiological flow rates: distinction from and prerequisite for adhesion through integrins. Cell 65: 1-20.
65. Prorok-Hamon M, Mathieu S, El-Battari A (2006) Visualizing intracellular distribution and activity of core2 b (1,6)-Nacetylglucosaminyltransferase-I in living cells. In: Brockhausen I, ed. Methods in Molecular Biology. Totowa, NJ: Human Press Inc. pp 171-187.